Arrowhead Pharmaceuticals

ARWR stock is not Shariah-compliant

مدعوم بواسطة Zoya API

About Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals develops medicines for the treatment of intractable diseases in the United States, with a pipeline of products targeting liver diseases, hypertriglyceridemia, angiopoietin-like protein 3, epithelial sodium channel alpha subunit in the airways, complement-mediated disease, chronic obstructive pulmonary disorder, facioscapulohumeral muscular dystrophy, uncontrolled gout, COVID-19, clear cell renal cell carcinoma, chronic hepatitis B virus infection, and cardiovascular targets. The company has collaboration agreements with Janssen Pharmaceuticals and Takeda Pharmaceuticals for developing RNAi therapeutics.

الأسئلة المتداولة

Is Arrowhead Pharmaceuticals (ARWR) stock halal to invest in?
Yes, ARWR is not Shariah-compliant based on the company’s latest financial reports and therefore considered halal to invest in. Last updated on Aug 27, 2024.
No, ARWR is not Shariah-compliant based on the company’s latest financial reports and therefore not considered halal to invest in. Last updated on Aug 27, 2024.
ARWR is flagged as not Shariah-compliant in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Arrowhead Pharmaceuticals's business that require careful consideration. Last updated on Aug 27, 2024.
Does Arrowhead Pharmaceuticals have any interest income?
Yes, Arrowhead Pharmaceuticals does have interest income. According to the company's latest annual report for the fiscal year ending Sep 30, 2023, Arrowhead Pharmaceuticals reported revenue of 240735000 and interest income of 15299000. The interest income represents 5.98% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Arrowhead Pharmaceuticals has not reported any interest income. According to the company's latest annual report for the fiscal year ending Sep 30, 2023, Arrowhead Pharmaceuticals reported total revenue of 240735000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Arrowhead Pharmaceuticals stock is Shariah-compliant?
نحن نستخدم المبادئ التوجيهية التي وضعتها هيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية (AAOIFI) لتقييم الامتثال للشريعة الإسلامية. هيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية هي منظمة دولية رائدة تضع معايير التمويل الإسلامي. تساعد إرشاداتها في تحديد ما إذا كانت الأنشطة التجارية للشركة و والهيكل المالي يتماشى مع المبادئ الإسلامية. وتحظى هذه المعايير باحترام واسع النطاق في وتوفر إطارًا متسقًا لتقييم مدى توافق الأسهم والأدوات المالية الأخرى مع الشريعة الإسلامية. والأدوات المالية الأخرى. وتضم الهيئة الشرعية لهيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية علماء مشهورين مثل الشيخ محمد تقي عثماني، والشيخ عبد الستار أبو غدة، والشيخ عبد الله المانع.
How often is Arrowhead Pharmaceuticals stock reviewed for Shariah compliance?
The Shariah compliance status of Arrowhead Pharmaceuticals stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Arrowhead Pharmaceuticals's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of ARWR, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Arrowhead Pharmaceuticals stock considered halal?
Yes, dividends from ARWR are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Arrowhead Pharmaceuticals (ARWR), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from ARWR are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Arrowhead Pharmaceuticals shares?
If you hold Arrowhead Pharmaceuticals stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on stocks can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculation tool. For an even easier experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Arrowhead Pharmaceuticals (ARWR) stock on Zoya

  1. سجّل للحصول على حساب زويا مجاناً
    من السهل البدء. يمكنك التسجيل للحصول على حساب مباشرةً على موقعنا الإلكتروني أو عن طريق تنزيل تطبيق زويا لنظامي iOS أو أندرويد.
  2. اربط حساب وساطة
    تتعاون Zoya مع شركات وساطة رائدة مثل Alpaca وغيرها من أجل طريقة سلسة لشراء الأسهم وإدارتها من خلال Zoya.
  3. حدد المبلغ الذي تريد استثماره
    انتقل إلى شاشة البحث واكتب اسم السهم في شريط البحث. بعد ذلك، انقر على زر الشراء وأدخل المبلغ الذي ترغب في استثماره، سواء بالدولار أو عدد الأسهم. راجع سعر السهم في الوقت الحقيقي وكمية الأسهم المقدرة قبل تأكيد استثمارك.
  4. قم بإدارة محفظتك في مكان واحد
    يمكنك العثور على الأسهم التي اشتريتها حديثًا في محفظة Zoya الخاصة بك إلى جانب بقية ممتلكاتك. قم بتمكين التنبيهات للحصول على إشعارات بأي تغييرات في امتثال محفظتك للشريعة الإسلامية.

منشورات المنتدى

الأسهم ذات الصلة

See how Arrowhead Pharmaceuticals compares with its peers: